– June. However, when considered the revenue from sales of goods for the 9-month period ended 30 September, 2018, there is a growth in overall performance with 18.65% when compared to the sales of 9-month
the Company for the period ending September 30, 2018. In this regard, there were no other connected transactions of the Company occurred during the past six months prior to the date on which the Board
sharing from investment in BBF. The major reasons were the increase in country’s total biodiesel production capacity, consequently, there was price competition of B100; together with glycerin price in
. According to temporarily closing of the branches and postponement of annual event, these affected of decreasing in same store sales at 61.1%, however, there is incremental in revenue from new branches that
production as there was no order presented, affecting the company directly during the second quarter of 2020. The situation also affected the company’s waste sent for treatment and disposal from our current
past, there are significant changes in groups including management structure, business operation structure and management strategy in order to increase business efficiency and growth, moreover suspend
contract has not yet been signed with the project owner. Should there be any update, the company will inform investors accordingly. The company certifies that this information is accurate and complete in all
Nomination and Remuneration Committee, is in the process of nominate a qualified and appropriate person to be a director for a vacant position. If there is any progress, the Company shall further inform the
, the gross profit will increase in the future, if there is an internal restructuring finished. DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร
, there is no demand for new installation. 2. Construction service income for the year sharply increased 207.40 Million Baht, accounting for 59.80% from previous year as the revenue recognition on progress